Abstract:AIM: To observe if the second filial generation of bisphosphonate-pamidronate disodium can inhibit the growth and induce the apoptosis of giant cell tumor (GCT) of bone cells. METHODS: The experiment was finished from March 2004 to November 2005 in Third Hospital of Peking University. ①The source of specimen: 10 fresh GCT tumor specimen was obtained from Department of Orthopaedics, Third Hospital, Peking University and Department of Orthopaedic Tumor Surgery of Beijing Jishuitan Hospital. All the specimens were confirmed by pathology. ②The primary GCT cell was gained from the tumor tissue and cultured in vitro. After the tumor cells were adhered, the experiment groups were added with pamidronate disodium into culture dish, culture flask and 96 holes culture plate as medication group at 5, 25, 50, 100, 200 μmol/L, respectively. The blank control group was added with phosphate buffer saline (PBS). To observe if GCT cell growth was inhibited. ③To detect the apoptosis of GCT cell with TUNEL: It was positive that there was amethyst particle in cell nucleus. The GCT cell apoptosis rate and the activation of caspase-3 were detected with flow cytometer. RESULTS: ①The culture of GCT cell: The cell of blank control group was normal and cell membrane was integrity. The cell of pamidronate disodium group was shrinked, pseudopodia were decreased, the contour was blurred, and the cell membrane was not integrity. The cell form was even disappear and disintegration. ②The inhibition of GCT cell growth: Pamidronate disodium could inhibit the growth of GCT cell. Along with the increase of concentration and lasting of affecting time, it was observed that the inhibition of growth was more obviously. ③TUNEL: The cell was found amethyst particle in cell nucleus of every concentration of pamidronate disodium group, while the blank control group was not found. ④The apoptosis rate detected by flow cytometer: After treated with pamidronate disodium at 5, 50, 200 μmol/L for 48 hours, the cell apoptosis rate was obviously higher than that in the blank control group [(20.48±6.02)%,(42.39±12.41)%,(54.67±15.38)%,(10.13±3.45)%,P < 0.05]. ⑤The detection findings of caspase-3 activation: After treated with pamidronate disodium at 5, 50, 200 μmol/L for 48 hours, the caspase-3 activation GCT cell was obviously higher than that in the blank control group [(14.93 ±5.04)%,(25.13±7.60)%,(26.07±7.49)%,(2.73±0.81)%,P < 0.05]. CONCLUSION: Pamidronate disodium can inhibit the growth of GCT cell and induce GCT cell apoptosis by stimulating the activation of caspase-3. It was dose-dependent and time-dependent. It is indicated that the pamidronate disodium will be possible used in treatment and prevention of recurrence of GCT.

Pamidronate disodium inhibits the growth of bone giant cell tumor and induces its apoptosis

Study of the Alendronate inhibiting growth and inducing apoptosis of giant cell tumor of bone in vitro

Gemcitabine inhibits cell growth and induces apoptosis of osteosarcoma cell line MG-63

Effect of Bisphosphonates on Local Recurrence of Giant Cell Tumor of Bone: a Meta-Analysis.

Fluorescent Mitoxantrone Hydrochloride Nanoparticles Inhibit the Malignant Behavior of Giant Cell Tumor of Bone via miR-125b/PTH1R Axis

Long-term Efficacy and Safety of Pamidronate Disodium in Treatment of Bone Metastases in Breast Cancer

Serglycin Induces Osteoclastogenesis and Promotes Tumor Growth in Giant Cell Tumor of Bone.

Efficacy and safety of denosumab combined with surgery in treatment of giant cell tumor of pelvis

Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC

Poly(lactic Acid) Electrospun Fiber Membranes Carrying Gemcitabine Hydrochloride Inhibit the Growth of Bone Tumor

Efficacy of chemotherapy combined with pamidronate disodium in treatment of cancer bone metastasis

Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone Via TP53INP1 Signaling

The experimental study of bisphosphonates inducing the expression of caspase-3 in the cells of bone giant cell tumor

Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint

Combined use of niraparib enhanced the inhibitory effect of Anti-GD2 antibody on osteosarcoma cells

Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence

Bioactive Glass Inhibits Tumor Development from Giant Cell Tumor of Bone-Derived Neoplastic Stromal Cells in a Chicken Chorioallantoic Membrane Assay

Study on inhibitory effects of RGD-conjugated gemcitabine-loaded albumin nanoparticles on the proliferation of BxPC-3 cells in vitro

Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft

Effect of RGD-conjugated Gemcitabine-Loaded Albumin Nanoparticles on Cell Cycle and Apoptosis of Pancreatic Cancer Cells

Effect of denosumab combined with surgery on sacral giant cell tumor